US clinical trial principles for conduct revised by the PhRMA, effective October

The Pharmaceutical Research and Manufacturers of America's (PhRMA) board of directors has unanimously endorsed measures to strengthen  PhRMA's Principles on Conduct of Clinical Trials and Communication of  Clinical Trial Results, stating that this reflects "the continued  commitment of America's pharmaceutical research and biotechnology  companies to encourage practices that best serve the needs of patients  and the health care community."

The newly-revised Principles, previously amended in 2004, "are part of  an ongoing effort to help ensure objectivity in research and enhance  transparency in clinical research," the PhRMA said.

PhRMA heeds calls "to do more" on ethical clinical trial conduct